-
2 weeks ago | 
usmedicine.com | Brenda Mooney
ROCHESTER, MN — Automated insulin delivery (AID) outperformed continuous glucose monitoring alone in Type 2 diabetes patients treated with insulin, according to a new study. The research, which involved 319 patients at 21 sites in the United States and Canada, including a VA hospital, supported the use of the devices in the management of insulin-treated Type 2 diabetes, not only in Type 1 diabetes.
-
1 month ago | 
usmedicine.com | Brenda Mooney
NEW YORK — More than a half-century after the United States escalated involvement in the Vietnam War by sending significant combat troops, veterans still face significant psychological and physical health challenges related to their employment.
-
1 month ago | 
usmedicine.com | Brenda Mooney
SEATTLE — Serious concerns were raised in a new VA study about the effectiveness of COVID-19 vaccines targeting the XBB.1.5 Omicron variant, which were introduced in September 2023.
-
1 month ago | 
usmedicine.com | Brenda Mooney
WASHINGTON, DC — VA Secretary Doug Collins announced in a video in late February that VA had cut $2 billion in cuts to contracts thus far. While he said the funds would be redirected to veterans’ health care and benefits, critics claimed the cuts will do the opposite. “We found nearly $2 billion in contracts that we’ll be canceling so we can redirect the funds back to Veterans health care and benefits,” Collins said.
-
1 month ago | 
usmedicine.com | Brenda Mooney
INDIANAPOLIS — A new VA-led study underscored the urgent need for clear guidelines on how best to treat chronic pain, especially when it comes to prescribing opioid pain medications.
-
1 month ago | 
usmedicine.com | Brenda Mooney
WASHINGTON, DC — With news every day about VA staffing cuts, the cancellation of contracts and, essentially, the way the agency does business, it is interesting to look back to what might seem to us as a simpler time – 60 years ago, when U.S. Medicine began. It wasn’t that simple to those living through it, however.
-
2 months ago | 
usmedicine.com | Brenda Mooney
NEW YORK — After peaking at 1.16% in 2017, the prevalence of opioid-use disorder (OUD) among VHA patients declined steadily and was 0.97% in 2022, the most recent date for which data is available. That’s according to a new Columbia University Irving Medical Center-led cross-sectional study that included approximately 5 million adults per year and determined that the prevalence of OUD increased from 2005 to 2017, reached its apex in 2017 at 1.16% and declined until 2022 to 0.97%.
-
2 months ago | 
usmedicine.com | Brenda Mooney
BETHESDA, MD — While the incidence rates of soft-tissue sarcomas are lower in young U.S. active-duty military servicemen compared with those in the general population, according to a new study, those are higher in middle-aged servicemen, possibly because of greater cumulative exposure to toxins.
-
2 months ago | 
usmedicine.com | Brenda Mooney
ST. Louis — While glucagon-like peptide-1 receptor agonists (GLP-1RA) are known to successfully treat diabetes and aid weight loss, they also have other widespread benefits, including for cognitive and behavioral health, as well as other conditions, according to review of a large cohort of U.S. veterans using the drugs.
-
2 months ago | 
usmedicine.com | Brenda Mooney
PALO ALTO, CA — The Systolic Blood Pressure Intervention Trial (SPRINT) found benefits of intensive vs. standard blood pressure (BP) control. But do those findings generalize to adults with chronic kidney disease (CKD)? That question was answered in a recent study led by Stanford University School of Medicine and the VA Palo Alto, CA.
